David Ting, MD is the Scientific Co-Founder of PanTher Therapeutics.
As a physician-scientist, cancer biologist, and bioengineer, David is currently Associate Clinical Director for Innovation, Co-Director Biomarker Discovery Lab, and a gastrointestinal oncologist at the Massachusetts General Hospital Cancer Center. He is also currently Associate Professor of Medicine at Harvard Medical School.
Prior to PanTher Therapeutics, David performed biomedical research under Dr. Robert Langer working on DNA vaccine delivery systems, and then a Howard Hughes Medical Institute fellowship at the Whitehead Institute at MIT working on stem cell biology with Dr. George Daley. David also co-founded TellBio, Inc. and ROME Therapeutics.
David holds an MD from Harvard Medical School from the Harvard-MIT Health Sciences and Technology program and a BS in both Chemical Engineering and Biology from MIT.